Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-100-7 | CAS number: 115-69-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral toxicity: key study in rats using APD (category member), 3 supporting studies from Category Members (AEPD and AMPD)
Dermal: key study in rabbits conducted on APD, one supporting study from category member AEPD
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Overall reporting of study is limited, but sufficient information to judge on hazard potential
- Justification for type of information:
- See attached (in chapter 13 of IUCLID) document with the justification for the category/read-across approach.
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1175 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): APD-1, 3
- Lot/batch No.: 227-124
- Analytical purity: No data - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- not specified
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Dosing solution was prepared by dissolving 5 g test material per 10 ml water (USP sterile water for injection).
- Doses:
- 5 g/kg bw
- No. of animals per sex per dose:
- 10 animals (sex not indicated)
- Control animals:
- no
- Details on study design:
- Animals dosed and then returned to cages for observation until day 14. Bodyweights were determined prior to dosing and on day of sacrifce (prior to euthenasia). All animals necropsied at sacrifice.
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 4 out of 10
- Clinical signs:
- other: 10/10 animals displayed piloerection and lethargy
- Gross pathology:
- Discoloration of the kidneys, liver, spleen and small intestine and signs of hemorrhaging in the stomach observed in the 4 animals that died.
- Other findings:
- none
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance, APD-1, 3 LOT #: 227-124, was evaluated for its potential to produce death following oral administration at a dose of 5 g/kg in male and female Sprague- Dawley rats. Based on the mortality (4/10 animals) in the Limit Test, the test substance is not classified for acute oral toxicity.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study is well conducted and well reported. Although no information on GLP compliance, the study appears to have been done in the spirit of GLP.
- Justification for type of information:
- See attached (in chapter 13 of IUCLID) document with the justification for the category/read-across approach.
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Cox-SD albino
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- AEPD was administered via gavage in a single aqueous dose solution (≤5 ml per animal).
- Doses:
- 0, 1800, 2500, 3500, and 5000 mg AEPD/kg bw
- No. of animals per sex per dose:
- 10 per sex per dose
- Control animals:
- yes
- Details on study design:
- Animals.
The rats used in this study were purchased at least four days before the test and allowed to acclimatize to the laboratory. Only the healthy animals, free of any sign of disease were selected for the study. The selected animals were fasted overnight and then gavaged with a selected dose. Each animal in the group was identified by a number. A card on the outside of a cage was used to identify the Specie, Sex, Test No., Material, Lot No., Dose, Starting and Ending Dates.
Diet:
The animals were fed Purina Certified Rodent Chow . Each utilized lot was identified and dated.
The diet was certified free of contaminants by the suppliers analysis.
Drinking Water:
Tap water was supplied ad libitum.
Every quarter the aninals' drinking water was analyzed to ensure that the levels of contaminants were equal to or less than the recommended levels as per the Primary Drinking water Regulations (40 CFR 141.11, 141.12, 141.14).
Test Material:
The material was tested as supplied. It was suspended in water.
Test procedure:
The test was carried out with 100 animals (50 nales, 50 females).
Treatment Groups: 10 males and 10 females per dose level (Each group represent one dose level) .
Control Group: 10 males and 10 females dose
Observation:
The animals be observed frequently on the day of dosing and daily thereafter for 14 days
Observations to include: signs of toxicity, poisoning, o r pharmacological effects, any unusual behavior and mortality
Body Weight.
Measured and recorded at day 0 , 7, and 14
Necropsy:
All animals which died during the observation period undergo a complete necropsy. The surviving animals sacrificed by ether. All major organs and
the body cavities exmined for gross abnormalities and then discarded. Any ununual observation recorded and reported.
Oral LD50:
Based on the mortality at the different dose levels, the oral LD50 value, 95 percentile confidence limits, slope, and the standard error are estimated
according to the method of Pinney ( P r o b i t Analysis, Cambridge Press. 1979) adapted t o BASIC computer program. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 3 882 mg/kg bw
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 571 mg/kg bw
- Mortality:
- Animals found dead had significant evidence of intestinal hemorrhage
- Clinical signs:
- other: After oral dosing of >2500 mg AEPD/kg both sexes developed eye squint by 6 hours.
- Gross pathology:
- At necropsy all animals had lung infection. The remaining organs examined grossly appeared normal.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 in male and female rats was 4571 mg/kg and 3882 mg/kg, respectively, with an average of 4227 mg/kg.
- Executive summary:
AEPD production lot (NPP41344) sample was tested in the rats to determine its toxicity and oral LD50 values. After oral dosing at doses >2500 mg/kg, male and female rats developed eye squint by 6 h. The surviving animals were normal by 24 h. The necropsy of the animals found dead during the observation period showed severe intestinal hemorrhage. On day 5 one of the male rats (#1) at 3500 mg/kg was found cannibalized. At 14 day necropsy of the surviving treated and control animals showed lung infection. The other organs in all the animals were grossly normal. The LD50 for males was calculated to be 4571 mg/kg and for females, 3882 mg/kg. AEPD is therefore considered to be of low acute toxicity.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study is well reported and appears to have been conducted according to current protocols and according to GLP.
- Justification for type of information:
- See attached (in chapter 13 of IUCLID) document with the justification for the category/read-across approach.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Remarks:
- Not designated in the abstract.
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of substance: 2-amino-2-ethyl-1,3-propanediol
- CAS No.: 115-70-8
- Purity: 99.4 %
- Characteristics: slightly yellow and transparent viscous liquid, with no contamination or visible foreign substances - Species:
- rat
- Strain:
- other: Crj:CD(SD)IGS
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- 21 female Sprague-Dawley SPF rats [Crj:CD(SD)IGS, Japan Charles River Co., Atsugi Breeding Center] were obtained at 7 weeks age and quarantined / acclimated for one week in Bozo labs. From observations during quarantine / acclimation, those considered healthy were randomly chosen and assigned to the experiment at 8 weeks age. Weight range was 179 – 211g, within +/- 20% of average values [average: 190g (152 – 228 g)].
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 200 and 3000 mg/kg
- No. of animals per sex per dose:
- Six
- Control animals:
- no
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No deaths were observed in both administration groups of 300 and 2000 mg/kg bw.
- Clinical signs:
- other: No abnormalities were observed in the general conditions in both groups of 300 and 2000 mg/kg bw
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No deaths occurred at either dose level, and the lethal dose was estimated to be higher than 2000 mg/kg. No abnormalities were observed in the general conditions or body weights of any animal or at necropsy.
Referenceopen allclose all
Four rats (4/10) died within 24 hours following administration of the Limit Dose of 5 g/kg. Abnormal clinical signs were observed in all (10/10) animals which included piloerection and lethargy. The four animals that died showed abnormal signs at gross necropsy including discoloration of the kidneys, liver, spleen and small intestine and signs of hemorrhaging in the stomach.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Reporting is limited, but sufficient information to judge the hazard potential
- Justification for type of information:
- See attached (in chapter 13 of IUCLID) document with the justification for the category/read-across approach.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1100 (Acute Dermal Toxicity)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- other: Albino
- Sex:
- male/female
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 24 hours
- Doses:
- 2g/kg bw
- No. of animals per sex per dose:
- 5 male and 5 female
- Control animals:
- not required
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- none
- Clinical signs:
- other: Nine out of ten of the animals exhibited slight to defined Erythema. One rabbit also exhibited Edema at the 24 hour scoring.
- Gross pathology:
- no effects
- Other findings:
- none
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material is considered non-toxic according to the procedures listed in the TSCA guidelines, 40 CFR, Part 798.
Reference
None of the test animals exhibited clinical signs of toxicity and all animals gained weight during the course of the study. Nine out of ten of the animals exhibited slight to defined Erythema. One rabbit also exhibited Edema at the 24 hour scoring. There were no visible lesions noted in any test animals upon gross observation at necropsy.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Oral toxicity:
The acute oral toxicity of the members of this category is low. All oral LD50 values in rats are >2000 mg/kg bw. Clinical signs observed in the available studies include lethargy and hunched posture, consistent with discomfort. Gross pathologial signs were consistent with the high pH of these materials (discoloration of the intestines and signs of hemorrhaging in the stomach). Value taken forward to CSR for acute oral toxicity of APD: LD50 >5000 mg/kg bw.
Dermal toxicity:
The acute dermal toxicity of the members of this category is low. The LD50 values from studies in rabbits are >2000 for APD and AEPD. Given the structural similarity it is assumed that the dermal toxicity of AMPD will be consistent with the other members of the category, and therefore also >2000 mg/kg bw. In the available studies, there were no clinical signs of toxicity other than some local effects (erythema/odema) immediatly following dosing. These subsided by the end of the study.
Value taken forward to CSA for APD: dermal LD50 >2000 mg/kg bw
Inhalation toxicity:
No studies are available for the substances in the category. However given the low toxicity via oral and dermal routes it is considered unlikely that these would pose an acute inhalation toxicity hazard. In addition, the vapour pressure of these substances is low, limiting the potential for an acute inhalation exposure to occur.
Justification for classification or non-classification
The LD50 values for oral and dermal routes are >2000 mg/kg bw, therefore no classification for acute toxicity is required according to DSD or CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.